Format

Send to

Choose Destination
See comment in PubMed Commons below
Drugs Today (Barc). 2011 Sep;47(9):683-91. doi: 10.1358/dot.2011.47.9.1682709.

Tissue transglutaminase antibodies in celiac disease: focus on the pediatric population.

Author information

1
Referral Center for Paediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, Zagreb, University Hospital Center "Sestre Milosrdnice", Zagreb, Croatia. ivahojsak@gmail.com

Abstract

Celiac disease (CD) is an immune-mediated disorder induced by the ingestion of gluten in genetically susceptible individuals. The enzyme tissue transglutaminase (protein-glutamine gamma-glutamyltransferase 2; tTG) plays an important role in the pathogenesis of the disease and antibodies against tTG are used as serological markers for the diagnosis of CD. Discovery of tTG as the autoantigen for endomysial antibodies changed the diagnostic approach to patients with suspected CD and, importantly, made screening for CD more accurate and easier to perform. Studies in pediatric populations confirmed the high sensitivity and specificity of immunoglobulin A (IgA) tTG antibodies in the diagnosis of CD. The aim of this review is to summarize the data on the role of tTG in the pathogenesis of CD and to present current evidence on the accuracy of IgA tTG, IgG tTG and IgA tTG point-of-care tests in the diagnosis of CD in children. This review shows why IgA tTG antibodies replaced endomysial antibodies as the preferred serological marker due to the ease of their use, their high sensitivity and specificity, and the high correlation between high titers and intestinal mucosal lesions.

PMID:
21971542
DOI:
10.1358/dot.2011.47.9.1682709
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Clarivate Analytics
    Loading ...
    Support Center